Virbac SA (EUR)
VIRP
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range215.00 | 225.50
52-Wk Range112.20 | 250.00
Last Close226.00
Mkt Cap (m)1,904.53
Dividend yield-
ISINFR0000031577
Volume10,453
Exchange VenuePAR

Company Profile

Virbac SA is a major drug manufacturer focusing on animal health. The company provides medicines feed supplements for animals. It operates in various therapeutic segments like Parasiticides, Disinfectants & Sanitizer, Hormones, Antibacterial, and Topical.

Key Information
Price/Earning55.53
Price/Book3.90
Price/Sales2.11
P/CF18.02
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Annual Report
en 31/12/2018

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)773853872862869-
Operating Income (m)11040666575-
Net Income (m)64935-320-
Basic EPS7.541.124.11-0.312.39-
Avg. Diluted Shares Outstanding (m)88888-
Balance Sheet
EUR201420152016201720182019
Current Assets (m)751486434401408-
Non Current Assets (m)575945984877865-
Total Assets (m)1,3261,4311,4171,2771,273-
Current Liabilities (m)558364393329331-
Total Liabilities (m)------
Total Equity (m)431438474436460-
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)764614210884-
Capital Expenditure (m)-40-43-40-38-34-
Figures are quoted in EUR unless stated otherwise
-8.00 (-3.54%)
218.00
Last Price